Director of Clinical Research at Associated Retina Consultants, and Clinical Assistant Professor at University of Arizona College of Medicine – Phoenix
A reviews of the TEASE-1 clinical trial with Benjamin Bakall, MD, PhD
The TEASE-1 trial reveals gildeuretinol's potential to reduce vision loss in Stargardt disease, offering hope for future treatments.
Read More